"prostate cancer treatment" trang 2 - tải miễn phí từ tailieuXANH
A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castrationresistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment

A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castrationresistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
8    79    0
Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment

Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment
9    37    1
Cancer patients’ knowledge about their disease and treatment before, during and after treatment: A prospective, longitudinal study

Cancer patients’ knowledge about their disease and treatment before, during and after treatment: A prospective, longitudinal study
11    60    0
Báo cáo khoa học:

Báo cáo khoa học: " The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer"
4    43    0
Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital

Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital
8    69    0
Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors
8    52    0
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
11    42    0
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells

Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
8    49    0
Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells

Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells
13    47    0
FERTILITY ISSUES IN CHILDHOOD CANCER TREATMENT

FERTILITY ISSUES IN CHILDHOOD CANCER TREATMENT
1    47    0
Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: A case report

Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: A case report
6    43    0
Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012

Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
7    81    0
TrueNTH sexual recovery study protocol: A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial

TrueNTH sexual recovery study protocol: A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial
13    65    0
Follow-up care after treatment for prostate cancer: Evaluation of a supported selfmanagement and remote surveillance programme

Follow-up care after treatment for prostate cancer: Evaluation of a supported selfmanagement and remote surveillance programme
18    56    0
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
9    65    0
Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: Study protocol for a randomised phase III trial (STEREO-OS)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: Study protocol for a randomised phase III trial (STEREO-OS)
10    42    1
Best Practice Policy Statement on Cryosurgery for the Treatment of Localized Prostate Cancer

Best Practice Policy Statement on Cryosurgery for the Treatment of Localized Prostate Cancer
51    32    0
Báo cáo y học:

Báo cáo y học: "A 12 Week, Open Label, Phase I/IIa Study Using Apatone® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy"
6    49    0
Báo cáo y học:

Báo cáo y học: "High-Resolution Flow Cytometry: a Suitable Tool for Monitoring Aneuploid Prostate Cancer Cells after TMZ and TMZ-BioShuttle Treatment"
10    53    0
Báo cáo khoa học:

Báo cáo khoa học: "[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph node"
8    44    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.